NEW YORK (GenomeWeb News) - GATC Biotech said today that it is coordinating an international effort to develop a microarray-based diagnostics test for bacterial and fungal pathogens that trigger sepsis.
GATC, based in Constance, Germany, said that it will function as the coordinating partner for project, which includes the Fraunhofer Institute in Germany and the National University of Pusan and Gene In Corporation, which are both located in South Korea.
The German Federal Ministry of Education, Science, Research and Technology will put up some of the funds for the research, the company added.
Each year, there are around 18 million cases of sepsis in the world, and between 28 percent and 50 percent of these infections are fatal, according to the company. GATC said the global financial cost of these illnesses total an estimated €7.6 billion ($10.7 billion).
The proposed diagnostic would “enable the immediate detection of organism-specific nucleic acid sequences, offering the advantage of reducing the time between sample collection and diagnosis, leading to a reduction in mortality rates,” the company said.
A timeline for completion of the diagnostic was not provided.